Recursion Pharmaceuticals Inc Cl A (RXRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2020 | 12-2019 | 12-2017 | 12-2006 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 264,126 | 75,171 | N/A | N/A |
| Receivables | 156 | 151 | N/A | N/A |
| Other current assets | 2,155 | 1,076 | 0 | 0 |
| TOTAL | $266,437 | $76,398 | $N/A | $N/A |
| Non-Current Assets | ||||
| PPE Net | 25,967 | 24,370 | N/A | N/A |
| Intangibles | 2,490 | 0 | 0 | 0 |
| Other Non-Current Assets | 3,691 | 663 | 0 | 0 |
| TOTAL | $32,148 | $25,033 | $N/A | $N/A |
| Total Assets | $298,585 | $101,431 | $N/A | $N/A |
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts payable and accrued liabilities | 1,074 | 1,261 | 0 | 0 |
| Accrued Expenses | 10,485 | 4,879 | N/A | N/A |
| Other current liabilities | 10,000 | N/A | N/A | N/A |
| TOTAL | $23,099 | $6,684 | $N/A | $N/A |
| Non-Current Liabilities | ||||
| Long Term Debt | 11,414 | 12,418 | N/A | N/A |
| Other Non-Current Liabilities | 19,375 | 3,207 | 0 | 0 |
| TOTAL | $33,463 | $17,903 | $N/A | $N/A |
| Total Liabilities | $56,562 | $24,587 | $N/A | $N/A |
| Shareholders' Equity | ||||
| Retained earnings | -213,601 | -126,595 | N/A | N/A |
| Other shareholders' equity | 448,312 | 201,109 | 0 | 0 |
| TOTAL | $242,023 | $76,844 | $N/A | $N/A |
| Total Liabilities And Equity | $298,585 | $101,431 | $0 | $0 |